Can you provide the average price target for IMMATICS NV stock?
17 analysts have analysed IMTX and the average price target is 18.87 USD. This implies a price increase of 93.74% is expected in the next year compared to the current price of 9.74.
IMMATICS NV (IMTX) Forecast, Price Target & Analyst Ratings
NASDAQ:IMTX • NL0015285941
Current stock price
9.74 USD
+0.54 (+5.87%)
At close:
9.74 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IMMATICS NV (IMTX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -€0.41
- Revenue Estimate
- 10.687M
Price Target Details & History
Consensus Price Target and Range
Mean target
$18.87
Upside
+ 93.74%
From current price of $9.74 to mean target of $18.87, Based on 17 analyst forecasts
Low
$11.11
Median
$17.34
High
$26.25
Price Target Revisions
1 Month
-1.60%
3 Months
1.65%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for IMTX. The average price target is 18.87 USD. This implies a price increase of 93.74% is expected in the next year compared to the current price of 9.74.
The average price target has been revised upward by 1.65% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
87.06%
IMTX was analyzed by 17 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about IMTX.
In the previous month the buy percentage consensus was at a similar level.
IMTX was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-11-19 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-09-18 | Guggenheim | Initiate | Buy |
| 2025-05-28 | Deutsche Bank | Initiate | Buy |
| 2025-04-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-19 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-07 | Piper Sandler | Initiate | Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-05 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-16 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-03-31 | Mizuho | Initiate | Buy |
| 2023-03-23 | Chardan Capital | Maintains | Buy |
| 2022-08-10 | Chardan Capital | Maintains | Buy |
| 2022-06-03 | SVB Leerink | Maintains | Outperform |
| 2021-07-15 | SVB Leerink | Maintains | Outperform |
| 2021-03-17 | SVB Leerink | Maintains | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -€0.41
- Revenue Estimate
- 10.687M
- Revenue Q2Q
- -42.49%
- EPS Q2Q
- -24.80%
- Number of Analysts
- 11
Next Earnings Revisions
Revenue (1 Month)
-26.45%
Revenue (3 Months)
-28.52%
EPS (1 Month)
-0.94%
EPS (3 Months)
-6.25%
Next Earnings Summary
IMTX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 10.69M USD.
The next earnings revenue estimate has been revised downward by 28.52% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 53.997M -68.75% | 155.835M 188.60% | 48.266M -69.03% | 44.152M -8.52% | 64.087M 45.15% | 116.24M 81.38% | 217.8M 87.37% | 413.5M 89.85% | 619.35M 49.78% | 902.14M 45.66% | 1.137B 26.03% | |
| EBITDA YoY % growth | -94.491M -355.38% | -26.39M 72.07% | -169.616M -542.73% | -228.644M -34.80% | -241.916M -5.80% | -367.451M -51.89% | -139.048M 62.16% | -129.61M 6.79% | 106.7M 182.32% | 461.42M 332.45% | 819.01M 77.50% | |
| EBIT YoY % growth | -101.725M -439.08% | -38.615M 62.04% | -182.016M -371.36% | -228.473M -25.52% | -147.952M 35.24% | -212.686M -43.75% | -161.974M 23.84% | -22.276M 86.25% | 124.35M 658.22% | 344.12M 176.74% | 535.12M 55.50% | |
| Operating Margin | -188.39% | -24.78% | -377.11% | -517.47% | -230.86% | -182.97% | -74.37% | -5.39% | 20.08% | 38.14% | 47.06% | |
| EPS YoY % growth | -1.20 -306.90% | 0.15 112.50% | -1.62 -1,180.00% | -1.59 2.06% | -1.56 1.86% | -1.47 5.91% | -0.98 33.22% | -0.33 66.61% | 0.25 175.71% | 1.13 357.53% | 1.94 71.82% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 -24.80% | -0.41 29.66% | -0.42 -0.06% | -0.40 -38.05% |
| Revenue Q2Q % growth | 10.687M -42.49% | 14.673M 209.75% | 14.796M 185.25% | 16.065M -18.70% |
| EBITDA Q2Q % growth | -53.547M -66.12% | -58.077M -23.67% | -60.604M -33.48% | N/A |
| EBIT Q2Q % growth | -55.33M -56.41% | -53.726M -1.13% | -55.588M -1.75% | -54.621M -40.48% |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
3.09%
EPS Next 5 Year
12.45%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
44.44%
Revenue Next 5 Year
60.71%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-24.72%
EBIT Next 5 Year
5.64%
IMMATICS NV / IMTX Forecast FAQ
Can you provide the upcoming earnings date for IMMATICS NV?
IMMATICS NV (IMTX) will report earnings on 2026-05-11.
What are the consensus estimates for IMTX stock next earnings?
The consensus EPS estimate for the next earnings of IMMATICS NV (IMTX) is -0.41 USD and the consensus revenue estimate is 10.69M USD.
What is the consensus rating for IMTX stock?
The consensus rating for IMMATICS NV (IMTX) is 87.0588 / 100 . This indicates that analysts generally have a positive outlook on the stock.